Advanced Search
PD1 Monoclonal Antibody Obtains the First 3-year OS for Advanced RCC Patients, etc[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 861-862. DOI: 10.3971/j.issn.1000-8578.2017.12.0001
Citation: PD1 Monoclonal Antibody Obtains the First 3-year OS for Advanced RCC Patients, etc[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 861-862. DOI: 10.3971/j.issn.1000-8578.2017.12.0001
shu

PD1 Monoclonal Antibody Obtains the First 3-year OS for Advanced RCC Patients, etc

    Graphical Abstract
    • Abstract
    • FullText(HTML)
  • loading
    • References (0)
    • Related Articles

Catalog

    Turn off MathJax
    Article Contents

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits： Visits today：

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return